Andrew Jarratt

Parkville, VIC 3052, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma.

High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 10, 2025

Resolving hematopoietic stem versus progenitor cell potential in the mouse dorsal aorta by differential Runx1 +110 enhancer activity.

Resolving hematopoietic stem versus progenitor cell potential in the mouse dorsal aorta by differential Runx1 +110 enhancer activity.

Journal: Cell reports
Published: July 15, 2025

Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial.

Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial.

Journal: British journal of cancer
Published: April 16, 2025

Genomics of ovarian cancers and the potential of precision medicine.

Genomics of ovarian cancers and the potential of precision medicine.

Journal: Therapeutic advances in medical oncology
Published: February 19, 2025

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Journal: Nature communications
Published: December 23, 2024

Genomics of cervical, vulvar and vaginal cancers and the potential of precision medicine.

Genomics of cervical, vulvar and vaginal cancers and the potential of precision medicine.

Journal: Therapeutic advances in medical oncology
Published: November 03, 2024

Genomics of uterine malignancies and the potential of precision medicine.

Genomics of uterine malignancies and the potential of precision medicine.

Journal: Therapeutic advances in medical oncology
Published: November 03, 2024

Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy.

Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy.

Journal: Blood
Published: February 22, 2022

Dissecting the molecular control of Interleukin 6 signaling using the M1 cell line.

Dissecting the molecular control of Interleukin 6 signaling using the M1 cell line.

Journal: Cytokine
Published: April 07, 2021

BAF complex-mediated chromatin relaxation is required for establishment of X chromosome inactivation.

BAF complex-mediated chromatin relaxation is required for establishment of X chromosome inactivation.

Journal: Nature communications
Published: January 10, 2021

Clonal multi-omics reveals Bcor as a negative regulator of emergency dendritic cell development.

Clonal multi-omics reveals Bcor as a negative regulator of emergency dendritic cell development.

Journal: Immunity
Published: August 06, 2020

A new lymphoid-primed progenitor marked by Dach1 downregulation identified with single cell multi-omics.

A new lymphoid-primed progenitor marked by Dach1 downregulation identified with single cell multi-omics.

Journal: Nature immunology
Published: September 11, 2019
Showing 1-12 of 13

Last Updated: 09/26/2026